By Matt Jones

NEW YORK (GenomeWeb News) – A new amendment to the patent reform bill in the US House of Representatives would enable patients to receive second opinions on the results of patented diagnostic genetic tests from alternate providers by enabling those testers to use the intellectual property and be protected from standard infringement suits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.